Circulating tumor DNA by next generation sequencing as a prognostic and predictive biomarker in metastatic colorectal cancer

被引：0
|
作者：
Jia, N. [1 ,2 ]
Chang, L. [3 ]
Dou, X. [1 ,2 ]
Guan, M. [1 ,2 ]
Shao, Y. [1 ,2 ]
Li, N. [1 ,2 ]
Cheng, Y. [1 ,2 ]
Ying, H. [1 ,2 ]
Sun, Z. [1 ,2 ]
Zhou, Y. [1 ,2 ]
Zhao, L. [1 ,2 ]
Zhou, J. [1 ,2 ]
Bai, C. [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Geneplus Beijing, Med Sci, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
552P
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Precision Monitoring by Next-Generation Sequencing in Lymphoma: Circulating Tumor DNA as a New Biomarker
    Gordon, Leo I.
    ONCOLOGY-NEW YORK, 2016, 30 (08): : 745 - 746
  • [12] Feasibility of next -generation sequencing of circulating tumor cells for predicting relapse after liver resection in metastatic colorectal cancer
    Larn, K.
    Ko, J.
    Chan, A.
    Choi, H.
    Dai, W.
    Lau, K.
    Wu, S.
    So, T.
    Lam, T.
    Chiang, C.
    Chang, W.
    Chan, M.
    Chu, K.
    She, W.
    Ma, K.
    Cheung, T.
    Wong, T.
    Chou, K.
    Lam, C.
    Wong, V.
    Lee, V.
    Lung, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [13] Measurement of circulating tumor DNA as a cancer biomarker in gastrointestinal malignancies using a novel next-generation sequencing method
    James, Edward Samuel
    Narayan, Azeet
    Stein, Stacey
    Lacy, Jill
    Patel, Abhijit
    Hochster, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [14] Methylated circulating tumor DNA in plasma as a biomarker for treatment efficacy in metastatic colorectal cancer
    Raunkilde, L.
    Hansen, T. F.
    Andersen, R. F.
    Jensen, L. H.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S713 - S713
  • [15] CIRCULATING TUMOR DNA IS A BIOMARKER OF METASTATIC BREAST CANCER
    不详
    CANCER DISCOVERY, 2013, 3 (05) : 482 - 482
  • [16] Circulating tumor DNA as biomarker in advanced colorectal cancer
    Deuter, M.
    Hussung, S.
    Philipp, U.
    Jolic, M.
    Waldeck, S.
    Follo, M.
    Gumenscheimer, M.
    Duque-Afonso, J.
    Becker, H.
    Bertz, H.
    Martini, V
    Axt, F.
    Souchon, S.
    Bleul, S.
    Mitschke, J.
    Marschner, N.
    Hoeppner, J.
    Fritsch, R.
    Duyster, J.
    Wehrle, J.
    Scherer, F.
    von Bubnoff, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 129 - 129
  • [17] Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
    Naidoo, Mahendra
    Piercey, Oliver
    Tie, Jeanne
    CURRENT ONCOLOGY REPORTS, 2021, 23 (12)
  • [18] Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
    Mahendra Naidoo
    Oliver Piercey
    Jeanne Tie
    Current Oncology Reports, 2021, 23
  • [19] Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer
    De Luca, Francesca
    Rotunno, Giada
    Salvianti, Francesca
    Galardi, Francesca
    Pestrin, Marta
    Gabellini, Stefano
    Simi, Lisa
    Mancini, Irene
    Vannucchi, Alessandro Maria
    Pazzagli, Mario
    Di Leo, Angelo
    Pinzani, Pamela
    ONCOTARGET, 2016, 7 (18) : 26107 - 26119
  • [20] Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma
    Affolter, Kajsa E.
    Hellwig, Sabine
    Nix, David A.
    Bronner, Mary P.
    Thomas, Alun
    Fuertes, Carrie L.
    Hamil, Cindy L.
    Garrido-Laguna, Ignacio
    Scaife, Courtney L.
    Mulvihill, Sean J.
    Underhill, Hunter R.
    NEOPLASIA, 2021, 23 (09): : 859 - 869
12345